Primary Site >> Pancreatic Cancer
Gene >> TFPI2
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. PMID: 15592528 |
Ref: DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. PMID: 16424060 Ref: Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma. PMID: 16965396 |
Ref: Structural templates predict novel protein interactions and targets from pancreas tumour gene expression data. PMID: 17646287 |
Ref: A case of pancreatic cancer with formation of a mass mimicking alcoholic or autoimmune pancreatitis in a young man. Possibility of diagnosis by hypermethylation of pure pancreatic juice. PMID: 18182742 Ref: DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease. PMID: 18995218 Ref: [Expression of TFPI-2 gene in pancreatic carcinoma and its prognostic significance]. PMID: 19102937 |
Ref: Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis. PMID: 19763915 |
Ref: Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo. PMID: 20018303 |
Ref: Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. PMID: 22083596 |
Ref: Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma. PMID: 25755762 Ref: Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma. PMID: 26504399 Ref: Increased matrix metalloproteinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinoma. PMID: 26807187 |
Ref: Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma. PMID: 27891190 |
Ref: Methylation of Tumor Suppressor Genes in Autoimmune Pancreatitis. PMID: 28196014 Ref: MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes. PMID: 28758420 Ref: Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging. PMID: 28857158 Ref: Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma. PMID: 29212200 |